🔗 Share this article

The top legal official in Texas Ken Paxton is filing a lawsuit against the producers of Tylenol, claiming the companies withheld potential risks that the drug created to children's brain development.

The court filing arrives thirty days after Donald Trump publicized an unproven link between taking Tylenol - also known as acetaminophen - throughout gestation and autism in young ones.

The attorney general is taking legal action against the pharmaceutical giant, which formerly manufactured the medication, the only pain reliever suggested for women during pregnancy, and the current manufacturer, which currently produces it.

In a official comment, he said they "betrayed America by making money from suffering and marketing drugs without regard for the dangers."

Kenvue says there is lacking scientific proof tying Tylenol to autism.

"These corporations deceived for years, deliberately risking millions to line their pockets," Paxton, from the Republican party, declared.

Kenvue stated officially that it was "very worried by the perpetuation of misinformation on the security of paracetamol and the potential impact that could have on the health of American women and children."

On its online platform, Kenvue also said it had "regularly reviewed the applicable studies and there is lacking reliable evidence that shows a established connection between using paracetamol and autism spectrum disorder."

Associations acting on behalf of physicians and health professionals concur.

ACOG has said acetaminophen - the primary component in acetaminophen - is one of the few options for women during pregnancy to manage pain and elevated temperature, which can pose major wellness concerns if ignored.

"In more than two decades of studies on the utilization of paracetamol in gestation, not a single reputable study has definitively established that the consumption of paracetamol in any stage of gestation results in neurodevelopmental disorders in children," the organization commented.

This legal action cites recent announcements from the Trump administration in asserting the drug is reportedly hazardous.

Recently, Trump caused concern from medical authorities when he told women during pregnancy to "struggle intensely" not to take Tylenol when ill.

Federal regulators then released a statement that doctors should think about restricting the use of acetaminophen, while also mentioning that "a proven link" between the medication and autism in minors has not been established.

Health Secretary RFK Jr, who manages the FDA, had pledged in spring to initiate "a massive testing and research effort" that would identify the source of autism in a limited time.

But authorities cautioned that identifying a single cause of autism spectrum disorder - considered by experts to be the consequence of a complicated interplay of inherited and environmental factors - would prove challenging.

Autism is a type of lifelong neurodivergence and condition that affects how people perceive and relate to the world, and is recognized using doctors' observations.

In his legal document, the attorney general - a Trump ally who is running for US Senate - claims Kenvue and J&J "willfully ignored and tried to quiet the research" around paracetamol and autism spectrum disorder.

The lawsuit attempts to require the corporations "remove any commercial messaging" that states acetaminophen is safe for expectant mothers.

This legal action mirrors the complaints of a assembly of guardians of young ones with autism and ADHD who sued the producers of acetaminophen in two years ago.

Judicial authorities rejected the lawsuit, saying investigations from the plaintiffs' authorities was lacking definitive proof.